Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Growth hormone treatment for severe fibromyalgia with somatotropic axis dysfunction
2006-005948-90Phase 3Completed
- Sponsor
- Serono
- Start
- Mar 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in fibromyalgia (FM) comparing Saizen with Placebo (2 arms). Primary endpoint: Primary efficacy endpoint. Started Mar 2007; status: completed.
02
Drugs
somatropin
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on 2006-005948-90.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005948-90.